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Summary
The Ink4a/Arf locus encodes two distinct proteins, both of which may contribute to senescence and tumor suppression.
We find that human diploid fibroblasts (HDFs) that are specifically deficient for p16INK4a achieve anchorage independence
when transduced with retroviruses encoding telomerase (hTERT) and either Ras or Myc. Significantly, Ras and Myc together
enable the cells to form tumors in nude mice but at a frequency that suggests additional genetic changes. All five tumors
analyzed expressed high levels of Ras and retained functional p53, although two showed downregulation of Arf. Cytogenetic
analyses identified clonal chromosomal alterations that may have contributed to tumorigenesis, but the tumor cells were
essentially diploid.
Introduction Serrano et al., 1997), it is clear that p19ARF is the critical determi-
nant of the ensuing growth arrest. Thus, MEFs from animals in
The concept of oncogene cooperation was first developed from which Arf has been specifically ablated by targeting of exon
studies on neoplastic transformation of primary rodent fibro- 1 are sensitive to transformation by Ras alone, a phenotype
blasts (Land et al., 1983; Ruley, 1983). Thus, whereas activated reminiscent of p53 nullizygous MEFs (Kamijo et al., 1997; Ta-
Ras will transform established lines, such as NIH3T3 cells, it naka et al., 1994). Moreover, Arf null or p53 null MEFs are
causes a senescence-like growth arrest in primary cells (New- immortal, and most established mouse cell lines have defects
bold and Overell, 1983; Serrano et al., 1997). Provision of a in one or other of these components. In contrast, Ink4a-deficient
second oncogene, classically cellular Myc or adenovirus E1A, MEFs are mortal and are arrested by Ras (Krimpenfort et al.,
rescues cells from this arrest and enables Ras to induce morpho- 2001; Sharpless et al., 2001). Oncogene cooperation by E1A
logical transformation, anchorage independence, and tumori- can therefore be rationalized by its ability to negate the pRb
genesis in immuno-compromised mice. These observations can family of proteins and render cells insensitive to p21CIP1, the
likely executor of the Arf/p53-mediated arrest, whereas Mycnow be rationalized in terms of effects on Ink4a/Arf.
This unusual locus encodes two products, p16INK4a and has a number of activities that would be compatible with a
bypass of p21CIP1effects (Bouchard et al., 1999; Claassen andp19ARF (p14ARF in human cells) that act upstream of the retinoblas-
toma (pRb) and p53 tumor suppressors, respectively (Drayton Hann, 2000; Coller et al., 2000; Hermeking et al., 2000; Herold
et al., 2002; Perez-Roger et al., 1999; Seoane et al., 2002; Vlachand Peters, 2002; Sharpless and DePinho, 1999; Sherr, 2001).
As p16INK4a blocks the inactivation of pRb by cyclin-dependent et al., 1996). An alternative view is that by activating Arf and p53,
Myc imposes a potent selection for cells that escape apoptosiskinases, and Arf blocks the inactivation of p53 by Mdm2-medi-
ated proteolysis, both have the capacity to cause cell cycle through loss of this defense pathway (Zindy et al., 1998).
With rare exceptions, attempts to reproduce oncogene co-arrest. Interestingly, although both are upregulated by Ras in
primary mouse embryo fibroblasts (MEFs) (Palmero et al., 1998; operation in human cells have been largely frustrated by their
S I G N I F I C A N C E
Human cells, including fibroblast strains that have been immortalized by telomerase, are generally resistant to transformation by
pairs of viral and/or cellular oncogenes that cooperatively transform primary rodent cells. However, neoplastic transformation has
recently been achieved using SV40 large and small tumor antigens in combination with hTERT and Ras. By starting with p16INK4a-
deficient HDFs, we have avoided the use of viral proteins and deliberate disruption of the p53 pathway so that the resulting tumors
are not aneuploid. As well as underscoring significant differences in the regulation of the Ink4a/Arf locus in human and rodent
fibroblasts, our data suggest that alterations in  four cellular genes can convert a primary human cell to a tumorigenic clone.
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propensity to undergo telomere-based senescence (Bischoff et
al., 1991; Hurlin et al., 1989; O’Brien et al., 1986; Stevenson
and Volsky, 1986), a property not shared by MEFs (Greenberg
et al., 1998; Martı´n-Rivera et al., 1998). However, the ability to
overcome telomere erosion by ectopic expression of the cata-
lytic component of telomerase (hTERT) has provided an oppor-
tunity to re-evaluate oncogene cooperation in HDFs (Bodnar et
al., 1998; Vaziri and Benchimol, 1998). The general impression
that has emerged is that transformation of human cells by Ras
requires the inactivation of both the pRb and p53 pathways,
typically achieved by introducing DNA tumor virus oncoproteins
such as SV40 large tumor antigen (T-Ag) or human papillomavi-
rus E6 and E7 proteins (Elenbaas et al., 2001; Hahn et al.,
1999; Morales et al., 1999; Serrano et al., 1997). However, full
neoplastic transformation additionally requires SV40 small tu-
mor antigen (Hahn et al., 2002). Although the influence of small
t is not fully understood, the need to disrupt both pRb and p53
could again reflect a pivotal role for Ink4a/Arf.
To address this question, we have been investigating the
behavior of primary dermal fibroblasts from melanoma-prone
individuals that have germline mutations in both alleles of Ink4a/
Arf (Brookes et al., 2002; Huot et al., 2002). In one case, a
homozygous deletion in exon 2 has created two novel frameshift
proteins that can be detected with monoclonal antibodies that
discriminate between the amino- and carboxy-terminal halves
of p16INK4a (Brookes et al., 2002). Importantly, these so-called
Leiden HDFs are specifically defective for p16INK4a and retain
the known functions of Arf. We previously demonstrated that
Leiden HDFs are resistant to Ras-induced arrest and, if rescued Figure 1. Expression of Myc and Ras in Leiden HDFs
from telomere-based senescence by ectopic hTERT, the Ras- Leiden HDFs immortalized with hTERT (LT cells) were infected with retroviruses
encoding Myc, MycRas, or empty vector controls. After drug selection,expressing cells will form anchorage-independent colonies.
the cell pools were analyzed by immunoblotting for the indicated proteins.They do not, however, grow as tumors in immuno-compromised
Note that Myc induces expression of the -ARF/p16 fusion protein (detectedmice. To try to achieve tumorigenic conversion using cellular
with a p16INK4a-specific antibody), as well as p53 and p21CIP1. Analogous
rather than viral gene products, we have now expressed Myc data for LT cells infected with the Ras retrovirus were reported elsewhere
and MycRas in Leiden cells. Interestingly, Myc also elicited (Brookes et al., 2002).
anchorage-independent growth of Leiden HDFs, but arrested
normal HDFs accompanied by upregulation of p16INK4a. In normal
HDFs, the Myc-induced arrest could be rescued using short
and enhance the phenotype, the LTR cells were infected withhairpin RNA (shRNA) against p16INK4a. The combination of
a pBABEpuro-based retrovirus encoding human c-Myc to gen-hTERT, Ras, and Myc enabled the p16INK4a-deficient cells to form
erate so-called LTRM cells. Alternatively, the LT cells were in-macroscopic colonies in soft agar and tumors in nude mice,
fected sequentially with retroviruses encoding Myc and Rasbut the latency and frequency of tumorigenesis suggested a
(designated LTM amd LTMR) in each case accompanied byneed for additional genetic alterations. Significantly, the resul-
control cells infected with the corresponding empty vector.tant tumor cells had near normal karyotypes and retained wild-
Pools of drug-resistant cells were then analyzed for expressiontype and functional p53.
of relevant proteins by immunoblotting (Figure 1). Although Myc
was clearly expressed in the infected cell pools, the signal wasResults
consistently lower in cells expressing ectopic Ras. However,
Myc activity seemed to be comparable in the different back-Myc causes anchorage independence
grounds as judged by the obvious induction of Arf, p53, andin p16INK4a-deficient HDFs
In a previous report (Brookes et al., 2002), we showed that p21CIP1. The Leiden deletion results in a frameshift protein
(-ARF/p16) in which the amino-terminal 88 residues of Arf areLeiden cells immortalized by hTERT (designated LT cells) do
not grow as anchorage-independent colonies but acquire this fused to the carboxy-terminal 76 residues of p16INK4a (Brookes
et al., 2002). This protein, which is readily detected with anability when infected with a retrovirus encoding an activated
(G12V) form of H-Ras (designated LTR cells). In contrast, control antibody against the carboxyl terminus of p16INK4a, retains all
known Arf functions, including the ability to stabilize p53 andHs68 fibroblasts underwent a senescence-like arrest in re-
sponse to Ras as predicted by other studies (Morales et al., hence to activate p53 target genes. The ability of Myc to activate
Arf is in line with previous findings in MEFs (Zindy et al., 1998),1999; Serrano et al., 1997; Wei et al., 1999). Although multicellu-
lar agar colonies occurred at a relatively high frequency with but there was no additive effect of coexpressing MycRas
(Figure 1). Although Ras induces Arf in MEFs (Groth et al., 2000;LTR cells, they remained small and were only visible by micros-
copy. To determine whether Myc would cooperate with Ras Palmero et al., 1998), it does not appear to do so in HDFs
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poration in both Leiden and Hs68 cells (Figures 2C and 2D),Table 1. Leiden cells expressing Myc and Ras form anchorage-independent
colonies consistent with knockdown of functional Arf in both cell types.
Vec Myc Vec Ras Vec Myc  Ras
Myc cooperates with Ras in morphological
Leiden  hTERT 0 32 3 42 0 35
and neoplastic transformationHs68  hTERT 0 0 0 0 0 0
of p16INK4a-deficient HDFs
Leiden and control (Hs68) fibroblasts expressing hTERT were infected with When plated in 0.2% agarose, Leiden cells expressing hTERTretroviruses encoding Myc, Ras, or both, with corresponding vector only
and Myc (LTM), Ras (LTR), or both oncogenes (LTRM) were allcontrols. Duplicate wells were seeded with 104 cells and colonies were
counted after 3 weeks. At least three fields of 100 cells were counted per able to form anchorage-independent colonies and at generally
well and the number of multicellular colonies calculated as a percentage similar frequencies (Table 1). However, there was a dramatic
of the total number of cells. increase in the average size of the colonies obtained with LTRM
cells so that many of them were macroscopically visible (Figure
3A). Moreover, by infecting LTM monolayers with appropriate
dilutions of Ras retrovirus, or LTR cells with Myc retrovirus,
effects reminiscent of focus formation were observed (Figure(Brookes et al., 2002; Wei et al., 2001). Note that Ras is clearly
3B and data not shown). The LTRM cells also appeared smalleractive in LTR cells as evidenced by the increased phosphoryla-
and more rounded, typical facets of morphological transforma-tion of Mek with no concomitant change in total Mek levels.
tion (Figure 3C).Despite increased levels of -ARF/p16, p53, and p21CIP1,
To determine whether the more exuberant growth of thethe Leiden cells expressing hTERT and Myc (LTM) continued
LTRM colonies equated with tumorigenicity, the various cellto proliferate and unexpectedly proved able to form colonies in
pools were injected subcutaneously into nude mice. No tumors0.2% agarose (Table 1), implying that Myc can both override
were observed with LTR or LTM cells in two separate experi-the Arf/p53 checkpoint and promote anchorage independence.
ments (Table 2). However, with LTRM cells, 5 out of 16 innocul-Although the ability of Myc to override effects of Cdk inhibitors
ations gave rise to tumors with a latency of between 59 and 98has been well documented (Alevizopoulos et al., 1997; Bouch-
days. For comparison, the positive control, the RDES Ewingsard et al., 1999; Perez-Roger et al., 1999; Vlach et al., 1996),
sarcoma cell line, formed tumors in 14/16 injections with a la-others have suggested that this causes Myc to arrest normal
tency of 23 to 28 days (Table 2). We therefore suspected thatHDFs in G2 (Felsher et al., 2000). Control Hs68 cells containing
a further alteration may have been required for the LTRM cellswild-type p16INK4a did not form anchorage-independent colonies
to grow as tumors.when infected with the Myc retrovirus (Table 1).
Phenotypic characteristics of LTRM tumor cellsMyc arrests normal HDFs by upregulating p16INK4a
When replated in tissue culture, the tumor cells retained all theThe different response of Leiden and Hs68 cells suggested
drug-resistant markers used for retroviral infections and grewthat p16INK4a is involved downstream of Myc. To investigate this
at approximately the same rate as the LTRM cells prior to inno-further, we used retroviruses encoding shRNAs to selectively
culation, albeit more rapidly than parental Leiden cells. Thereduce the expression of INK4a or ARF (Voorhoeve and Agami,
most obvious characteristic was reduced adhesion, with a high2003). The shRNA retroviruses and empty vector controls were
proportion of floating but otherwise viable cells. Integrin profilingintroduced into Hs68 and Leiden cells (without hTERT), and the
revealed consistent reductions in 11, 41, v5, and v3
resultant pools of hygromycin-resistant cells were subsequently
relative to parental Leiden cells (Figure 4A and additional data
infected with the Myc retrovirus (pBABEpuro) or the correspond-
not shown). However, most of the effects were already apparent
ing empty vector. At 12 days post-selection, the cells were in the LTR, LTM, and LTRM cell pools (Figure 4B), suggesting
labeled with BrdU and lysates were prepared for immunoblot- that they may contribute to anchorage independence rather
ting. In Hs68 cells, Myc caused a substantial upregulation of than being a characteristic acquired during tumor formation. It
p16INK4a (Figure 2A) accompanied by reduced incorporation of will be interesting to explore whether Ras and Myc affect surface
BrdU into DNA (Figure 2C). Significantly, the cells were rescued integrin expression by similar mechanisms. We also noted that
from this growth arrest by shRNA against p16INK4a but not by the tumor cells were able to proliferate in low serum, suggesting
shRNA against p14ARF (Figure 2C). In Leiden cells, which lack the production of autocrine growth factors. When conditioned
functional p16INK4a, Myc had no effect on BrdU incorporation, medium from tumors T1 through T5 was added to serum-
irrespective of shRNA expression (Figure 2D). These data are deprived Hs68 cells, it was able to promote re-entry into the
consistent with the notion that, in primary HDFs, p16INK4a is the cell cycle as judged by incorporation of BrdU (Figure 4C, right
principal determinant of the growth arrest elicited by Myc. panel). Again, this property was not peculiar to the tumor cells
The abilities of Myc to induce p16INK4a and of shRNA to as we noted similar effects with conditioned medium from pools
suppress this effect were readily demonstrated in Hs68 cells of LTR, LTM, and LTRM cells (Figure 4C, left panel).
(Figure 2A). In contrast, it is very difficult to visualize the endoge- Whereas Myc levels in the tumor cells were similar to those
nous levels of Arf in primary HDFs and therefore to document in the LTRM cells, all of the tumors expressed elevated levels
suppression by shRNA. However, as the -ARF/p16 fusion pro- of Ras (Figure 5A). Southern blotting analyses did not reveal
tein in Leiden cells can be visualized using a monoclonal anti- abnormally high copy numbers of the Ras retrovirus (not shown),
body against p16INK4a (Brookes et al., 2002), we were able to but there may have been selection for integration sites that favor
confirm the efficacy of the shRNA in reducing basal levels of high expression or for other epigenetic events that we have not
Arf and its induction by Myc (Figure 2B). Moreover, shRNA fully investigated. The tumors also had very high levels of p53,
accompanied by increased expression of two p53 target genes,against Arf had a positive, albeit modest impact on BrdU incor-
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Figure 2. Myc arrests HDFs by upregulating
p16INK4a
Normal (Hs68) and Leiden HDFs were infected
with pRetroSuper encoding shRNA against either
Arf or Ink4a (Voorhoeve and Agami, 2003), along
with the empty vector control, and selected in
hygromycin. The cell pools were subsequently
infected with a retrovirus encoding Myc, and
corresponding control, and selected in puro-
mycin.
A and B: Cell lysates were analyzed by immu-
noblotting with antibodies against Myc, Mek,
and p16INK4a. The p16INK4a in Hs68 cells was de-
tected using the JC8 monoclonal antibody, and
the -ARF/p16 fusion protein in Leiden cells was
detected using DCS50 (Brookes et al., 2002).
C and D: Cell proliferation was assessed by pulse
labeling with BrdU and measuring the proportion
of BrdU-positive cells by immunohistochemistry.
Cip1 and Mdm2, albeit to variable but essentially parallel extents cells and in three of the tumors, it was undetectable in tumors
T1 and T5 (Figure 5A). Southern blotting confirmed that the(Figure 5A). There was some concordance between cyclin E
and Mdm2 levels, being highest in tumors T1 and T2, but the Ink4a/Arf locus was intact in all the tumors (not shown), but we
did not detect an Arf transcript in T1 and T5 by RT-PCR (Figuresignificance remains unclear as there was no apparent relation-
ship to the expression of Myc or Ras. Similarly, neither cyclin 5C). Such a situation is often indicative of de novo methylation,
but we have been unable to reactivate Arf expression in theseD1, a known Ras target (Filmus et al., 1994), nor cyclin D2, a
known Myc target (Bouchard et al., 1999; Coller et al., 2000), cells by addition of 5-aza-deoxycytidine under conditions that
will induce Arf expression in U20S cells (not shown). Sequencingappeared to be significantly overexpressed in the tumor cells
(Figure 5A and data not shown). of the PCR products confirmed that the -ARF/p16 expressed
in tumors T2, T3, and T4 had not sustained inactivating muta-As high basal levels of p53 can be indicative of stabilizing
mutations, we analyzed the p53 gene in each of the tumors by tions (not shown). Although we presently have no evidence that
the p53 pathway is defective in the other tumors, at this levelperforming SSCP and DNA sequence analyses on all 11 exons
(not shown). No mutations were detected. We also checked of analysis we cannot exclude alterations in specific upstream
regulators or downstream effectors of p53.p53 function by demonstrating the accumulation of p53 and
upregulation of p21CIP1 when the tumor cells were exposed to
UV irradiation (Figure 5B). Given the precedents in MEFs, reten- Cytogenetic analyses of LTRM tumor cells
We were interested to know whether maintenance of functionaltion of wild-type p53 could also reflect loss of Arf (Kamijo et
al., 1997), and we previously demonstrated the functionality of p53 had enabled the LTRM tumor cells to avoid aneuploidy
and to determine whether additional genetic alterations hadthe -ARF/p16 fusion protein in Leiden HDFs (Brookes et al.,
2002). Although the fusion protein was readily detected in LTRM occurred that were karyotypically visible. The LTRM tumor cells
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Table 2. Formation of tumors in immunodeficient nude mice
Number of Time
Cells injected tumors (days) Mouse Tumor
LT 0/8
LTR 0/8
LTM 0/8
LTRM 2/8 98 #9 T1
77 #12 T2
RDES 6/8 28
LTR 0/8
LTM 0/8
LTRM 3/8 59 #C9R T3
59 #C9L T4
98 #C10 T5
RDES 8/8 23
Leiden cells expressing combinations of hTERT, Ras, and Myc (LT, LTM, LTR,
and LTRM) were tested for tumorigenicity by injection into nude mice. The
LTRM cells formed tumors at 5/16 inoculation sites in the indicated mice
after 59–98 days. Tumors designated T1–T5 as indicated were explanted
and grown in tissue culture.
populations, tumors T3 and T4 were mixed populations, includ-
ing some cells that had neither abnormality (Figure 6E). The
tumors with the iso18q abnormality corresponded to those in
which Arf had been downregulated and were also the tumors
with the longest latency (Table 2). However, it is impossible to tell
at this stage whether the chromosome alterations were causal in
tumorigenesis or represented clonal markers of cells bearing
more subtle alterations that are undetectable at the karyotypic
level.
Discussion
Figure 3. Myc and Ras cause anchorage independence and morphologi- The availability of cells with a specific genetic defect in Ink4a
cal transformation of LT cells and the capacity to immortalize these cells with hTERT have
A: Appearance of anchorage-independent colonies approximately three provided an unprecedented opportunity to investigate onco-
weeks after seeding 104 cells in 0.2% agarose. Note that colonies induced
gene cooperation in human cells. In this genetic context, weby Ras (LTR cells) were visible by microscopy (see Table 1 and Brookes et
find that Ras and Myc, dominant oncogenes that are frequentlyal., 2002).
B and C: Low and high power photomicrographs, respectively, of LTM cells implicated in human cancers, collaborate to induce anchorage
infected with a 1:100 dilution of the Ras retrovirus or vector control (pBABE- independence and tumorigenicity in otherwise normal HDFs.
bleo). Cells were stained with Geimsa for 20 min and washed with water. However, our findings with Leiden cells have to be set against an
extensive literature on the neoplastic transformation of primary
MEFs, as well as recent advances in transformation of human
cells (Drayton and Peters, 2002). In primary MEFs, which areand the parental LTRM cell pools were therefore analyzed by
not subject to telomere-based senescence, it appears that twousing multicolor chromosome paints (M-FISH) on metaphase
genetic alterations are sufficient for all facets of transformation,spreads (Eils et al., 1998) and by comparative genome hybridiza-
including anchorage independence and tumorigenicity. In addi-tion (CGH) on gridded arrays of bacterial artificial chromosomes
tion to the classical RasMyc pairing (Land et al., 1983), specific(BACs) containing human genomic DNA (Pinkel et al., 1998).
disruption of either p53 or Arf creates a situation in which primaryWhile the LTRM cells were diploid and showed no evidence of
MEFs can be transformed by Ras alone (Kamijo et al., 1997;chromosomal abnormality (not shown), two consistent changes
Tanaka et al., 1994). Conversely, MEFs in which Ink4a has beenwere observed in the tumors. The first was iso18q (see Figure
ablated remain sensitive to Ras-induced arrest (Krimpenfort et6A), which in CGH showed as a loss of the p and gain of the
al., 2001; Sharpless et al., 2001), in stark contrast to our findingsq arm of chromosome 18 (Figure 6B). Further confirmation was
with p16INK4a-deficient HDFs (Brookes et al., 2002; Huot et al.,subsequently obtained using FISH with a probe for the telomere-
2002). As Ras activates Arf in MEFs but not in HDFs (Brookesproximal region of chromosome 18 (not shown). The second
et al., 2002; Groth et al., 2000; Palmero et al., 1998; Wei et al.,abnormality was a gain of material on chromosome 20q and its
2001) whereas Myc has a more substantial effect on p16INK4a intranslocation to chromosome 14 (Figure 6C). In CGH, this
HDFs than in MEFs (Mateyak et al., 1999; Zindy et al., 1998;scored simply as a gain on 20q, but the sharp step in the
data not shown), we surmise that the mechanisms underpinninghybridization signal showed that the discontinuity occurred pre-
oncogene cooperation may differ in these settings.cisely at BACs corresponding to 20q1.2 (Figure 6D). Surpris-
ingly, while tumors T1, T2, and T5 appeared to represent clonal The dominance of rodent models in transformation studies
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Figure 5. Gene expression patterns in LTRM cells and tumors
Figure 4. LTRM cells are less adhesive and release autocrine growth factors A: Immunoblotting for the indicated proteins in LT and LTRM cell pools and
the LTRM tumors T1–T5. Mek signals confirmed equal loading.A: Levels of the indicated integrins in LTRM cells and tumors T1–T5 are shown
B: Induction of p53 and p21CIP1 in LTRM and tumor cells 18 hr after UV irrada-relative to those in parental LT cells.
tion (15J/m2) as described (Brookes et al., 2002).B: A similar analysis comparing the LT, LTR, LTM, and LTRM pools.
C: Reverse transcription-PCR detection of Arf (540 bp product) and Cdk4C: Ability of LTRM cells to produce autocrine growth factors. The indicated
(936 bp product) in LTRM cells and tumors T1–T5.cells were placed in medium containing 0.2% FCS for 48 hr, at which point
conditioned medium was recovered and added to Hs68 cells that had
been rendered quiescent in 0.2% FCS. The cells were then labeled with BrdU
for 16 hr and the proportion of BrdU-positive cells estimated by immunohisto-
chemistry. Medium containing either 0.2% or 10% serum represented nega-
MycRas focus formation assay has been difficult to reproducetive and positive controls, respectively. The left and right panels show results
from separate experiments. in human cells, even if they have been immortalized by hTERT.
Here we have bypassed the problem using cells that are spe-
cifically deficient for p16INK4a, whereas most other studies have
relied on using DNA tumor virus oncoproteins to render cellscan in part be explained by the difficulties involved in culturing
insensitive to p16INK4a (Bischoff et al., 1991; Elenbaas et al., 2001;human cells. Ectopic delivery of hTERT has removed one of the
Hahn et al., 1999, 2002; Morales et al., 1999; O’Brien et al.,obstacles, effectively equalizing the telomere status of HDFs
1986; Rich et al., 2001; Zimonjic et al., 2001). The disadvantageand MEFs, but p16INK4a provides a second barrier to the contin-
of the latter approach is that ablation of pRb inevitably leadsued propagation of human cells (Drayton and Peters, 2002).
to activation of the Arf/p53 pathway, making it necessary toThe stress of growing cells under normal culture conditions is
disable p53 as well (Drayton and Peters, 2002; Sharpless andenough to activate p16INK4a, albeit to different extents in different
DePinho, 1999; Sherr, 2001). By preserving both pRb and p53,contexts (Sherr and DePinho, 2000; Wright and Shay, 2002),
we have avoided the pleitropic consequences and aneuploidyand oncogenic challenge with Myc and Ras can clearly exacer-
bate the effects. This could in part explain why the classical associated with disruption of these pathways. It is nevertheless
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Figure 6. Genome integrity of LTRM tumor cells
A and C: Examples of M-FISH analyses on individual tumor cells revealing the iso18q and t(14;20) abnormalities, respectively.
B and D: Detection of the corresponding abnormalities in tumors T1 and T2 by CGH on gridded BAC arrays. Only the relevant chromosomes are displayed.
E: Proportions of cells with the indicated karyotypes in each tumor.
intriguing that tumors T1 and T5 have downregulated Arf, rein- 1999; Evan et al., 1992; Zindy et al., 1998). With HDFs, growing
in 10% serum, we have not observed extensive apoptosis uponforcing our belief that the -ARF/p16 fusion protein in Leiden
cells is functional (Brookes et al., 2002). Moreover, ablation of expression of Myc despite obvious upregulation of Arf and p53
(Figure 1 and additional data not shown). In the case of LeidenArf with shRNA consistently resulted in increased proliferation,
as judged by BrdU incorporation (Figures 2B and 2C). Con- cells, they may have been protected from apoptosis by the
production of autocrine growth or survival factors, and it will beversely, the knockdown of -ARF/p16 expression with shRNA
did not suppress the formation of anchorage-independent colo- important to establish the identity of these factors and that the
phenomenon is not unique to Leiden cells (Figure 4B). Thisnies (data not shown).
Based on precedents in other systems, one might expect seems unlikely given the precedents for autocrine signaling in
Ras-transformed cells (McCarthy et al., 1995); we are not awareMyc to provide selective pressure against the Arf/p53 pathway
in order to avoid apoptosis or cell cycle arrest (Eischen et al., of previous reports that Myc can enable cells to condition the
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medium. In terms of overcoming a p53/p21-mediated growth ments for tumorigenesis (Elenbaas et al., 2001; Lazarov et al.,
2002; Rich et al., 2001; Watnick et al., 2003; Zimonjic et al.,arrest, there are many potential explanations in the literature,
including the ability of Myc to upregulate cyclin D2, Cdk4, Cul1, 2001).
and Cdc25A and to suppress transcription of p21CIP1 (Bouchard
Experimental procedureset al., 1999; Claassen and Hann, 2000; Coller et al., 2000; Galak-
tionov et al., 1996; Hermeking et al., 2000; Herold et al., 2002;
Cells, agar colony, and tumorigenicity assays
O’Hagan et al., 2000; Perez-Roger et al., 1999; Seoane et al., Leiden and Hs68 cells expressing the ecotropic receptor were immortalized
2002). Based on the analyses conducted thus far, we are unable with a retrovirus encoding hTERT (in pBABEhygro) at approximately 30 PD
to implicate or exclude any of these mechanisms. The ability and 50 PDs, respectively, as described previously (Brookes et al., 2002).
At approximately 50 PD and 90 PD, respectively, the cells were infectedof Myc to repress the expression of p21CIP1 is only apparent in
sequentially with retroviruses encoding H-RasV12 (pBABEbleo) or Myccells that have defects in the Arf/p53 pathway (Herold et al.,
(pBABEpuro) along with empty vector controls. For the shRNA experiments,2002; Seoane et al., 2002) and does not apply here. Moreover,
Leiden and Hs68 cells (without hTERT) were infected with pRetroSuper-
as the tumor cells have probably adapted to a new steady state, hygro vectors encoding short RNA hairpins directed against Ink4a or Arf
differences in the expression levels of various components (Voorhoeve and Agami, 2003). Pools of infected cells were selected in me-
could be relatively subtle. dium containing 50 g/ml hygromycin, 200 g/ml zeocin, or 1.25 mg/ml
puromycin as appropriate, with each infection requiring the equivalent ofThe notion of adaptation may be relevant in considering
approximately 8 PDs.whether our findings with Leiden cells are universally applicable
For anchorage independence assays, approximately 104 cells wereor reflect some unique property of this strain of HDFs. As we
seeded in Dulbecco-modified Eagles medium (without phenol red) containingpreviously reported (Brookes et al., 2002), infection of LT cells
0.2% agarose and 10% fetal calf serum (FCS) and overlayed on medium
with a Ras retrovirus elicits a transient phase of reduced prolifer- containing 1% agarose. Cells were incubated at 37C and multicellular colo-
ation which we interpret as the emergence of a subpopulation of nies were counted after approximately three weeks. Results were calculated
as the percentage of visible cells that had formed multicellular colonies.cells that tolerate the sustained Ras signaling. There presumably
Duplicate wells were seeded in each assay and at least three fields of 100has to be a balance between the dose of exogenous Ras and
cells were counted per well.the efficiency of the cellular defense mechanisms, which in the
For each cell type, aliquots of 107 cells (in 0.2 ml) were injected subcuta-absence of functional p16INK4a may be largely determined by the
neously on both flanks of four YA female nu/nu mice. This entailed growing
p53 pathway. As our functional assessment of the -ARF/p16 the various immortalized cell pools for a further 25–30 PDs. The RDES
fusion protein suggests that it may be hyperactive relative to Ewings sarcoma cell line was used as a positive control. Mice were observed
normal Arf (Brookes et al., 2002), it is conceivable that this has for tumor development, and injection sites were measured twice weekly until
tumors reached approximately 1 cm in diameter or until no observable massresulted in some compensatory attenuation of the p53 pathway
of cells was left at the injection site. After dissection, tumor explants werethat has thus far eluded detection. On the other hand, so-called
dispersed with trypsin and replated in standard tissue culture conditions.normal HDFs derived from different individuals are likely to have
different basal and induced levels of p53, just as they have Protein analyses
widely different levels of p16INK4a (Itahana et al., 2003 and J.R. Samples (50 g protein) of total cell lysate were fractionated by electrophore-
and G.P., unpublished observations). It will therefore be impor- sis in 10% or 15% polyacrylamide gels, transferred to PVDF membrane,
and immunoblotted under standard conditions for enhanced chemilumines-tant to reevaluate the requirements for transformation in a variety
cence. A variety of polyclonal and monoclonal antibodies were used toof different HDF strains.
detect the following proteins: cyclin D1 (287.3), cyclin D2 (DCS3.1), -ARF/At face value, the data we describe imply that functional
p16 (DCS50), p16INK4a (JC8), Myc (9E10); Cdk4 (sc-601), p53 (sc-26/D0-1alterations in four cellular genes are necessary for neoplastic
and sc-6243/FL-393), and p21CIP1 (sc-397) from Santa Cruz; Mdm2 (OP115/
conversion of primary HDFs but may not be sufficient. The 2A10) and Ras (OP41) from Oncogene Science; Mek1 and 2 (9122) and
frequency and latency of tumor incidence suggest at least one phospho-Mek (9121S) from Cell Signaling Technology; p21CIP1 (554228) from
additional change, but at present we can neither rule in nor rule PharMingen 554228; and cyclin E (HE12) from NeoMarkers.
out the significance of the specific chromosomal alterations
BrdU incorporation and autocrine signaling assaysobserved in the tumors analyzed thus far. It will of course be
Cells were grown on 35 mm glass-bottomed cell culture dishes, labeledinteresting to determine whether other oncogenes can substi-
with 5 mM BrdU for 16 hr, and stained for BrdU incorporation using the
tute for Myc and/or Ras in the transformation of Leiden cells Boehringer Mannheim BrdU labeling and detection kit. BrdU incorporation
and whether deliberate ablation of p53 influences the latency was measured by counting the proportion of positively stained cells.
and frequency with which tumors develop. Although the original To investigate autocrine signaling, Hs68 were trypsinized, washed in
LTRM pool gave rise to tumors at only 30% of the innoculation PBS, and plated at subconfluent density in 35 mm glass-bottomed dishes
in Dulbecco-modified Eagles medium contaning 0.2% FCS. The mediumsites, reinjection of the explanted tumor cells gave frequencies
was replaced after 24 hr and the cells became quiescent by 48 hr. Pools ofapproaching 100% (not shown), emulating the results achieved
LT, LTR, LTM, and LTRM cells and the T1–T5 tumor cells were treated inwith viral oncoproteins (Hahn et al., 1999). An intriguing question
the same way, and medium collected from these cultures at 48 hr was
is whether additional genetic changes in the LTRM tumors mimic centrifuged to remove debris. The conditioned medium was placed directly
the role of SV40 small t antigen in tumor cell systems based on the quiescent Hs68 cells. Parallel dishes received medium containing
on using the SV40 early region to ablate pRb and p53 (Elenbaas either 0.2% FCS (negative control) or 10% FCS (positive control). BrdU
incorporation was measured as above.et al., 2001; Hahn et al., 2002). The fact that the LTRM tumors
have simple and stable karyotypes opens up the possibility of
Integrin profilingidentifying these changes, for example, by a combination of
The LTRM and tumor cells (T1–T5) were analyzed for changes in the levelscytogenetics and gene expression profiling on microarrays.
of surface integrins using monoclonal antibodies specific for 1, 2, 3, 4,
Moreover, the availability of shRNA against p16INK4a should en- 5, 6, 9, v, v3, v5, v6, 1, 3, 4, IIb. Bound antibodies were
able these ideas to be tested in a selection of otherwise normal detected with FITC-conjugated anti-mouse secondary antibody (Alexa 488)
with the exception of 6, which was detected with FITC-conjugated anti-HDFs as well as in cell lineages that may have different require-
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Claassen, G.F., and Hann, S.R. (2000). A role for transcriptional repressionrat secondary antibody. Cells were then analyzed by FACS. Secondary
of p21CIP1by c-Myc in overcoming transforming growth factor -induced cell-antibody alone served as a negative control. Integrin IIb (which is platelet
cycle arrest. Proc. Natl. Acad. Sci. USA 97, 9498–9503.specific) and 4 (which is epithelial specific) also gave negligible staining.
The HT1080 fibrosarcoma cell line served as a positive control. The results Coller, H.A., Grandori, C., Tamayo, P., Colbert, T., Lander, E.S., Eisenman,
for each integrin were normalized relative to parental LT cells. R.N., and Golub, T.R. (2000). Expression analysis with oligonucleotide mi-
croarrays reveals that MYC regulates genes involved in growth, cell cycle,
Reverse transcription, PCR, and sequencing signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97, 3260–3265.
Total RNA was extracted from cultures of the tumor-derived cells T1–T5
Drayton, S., and Peters, G. (2002). Immortalisation and transformation revis-using the QIAGEN RNeasy mini kit and reverse-transcribed using TaqMan
ited. Curr. Opin. Genet. Dev. 12, 98–104.reverse transcription reagents (Applied Biosystems) under conditions recom-
mended by the suppliers. Products corresponding to -ARF/p16 cDNA were Eils, R., Uhrig, S., Saracoglu, K., Satzler, K., Petersen, I., Chassery, J.M.,
amplified by PCR using the following primers: CGGTGCGTGGATCCCAGTC Ganser, M., and Speicher, M.R. (1998). An optimized, fully automated system
TGCAGTTAAG (forward) and CTGTAGGACCTTCGG-TGACTG (reverse). The for fast and accurate identification of chromosomal rearrangements by multi-
primers for Cdk4 were CCGGATCCACCATGGCTACCTCTC-GATATGA (for- plex-FISH (M-FISH). Cytogenet. Cell Genet. 82, 160–171.
ward) and CTGGAATTCGAATCACTCCGGATTACCTTCATC (reverse). PCR
Eischen, C.M., Weber, J.D., Roussel, M.F., Sherr, C.J., and Cleveland, J.L.products were separated on a 1% agarose gel containing 0.5 g/ml ethidium
(1999). Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-bromide and visualized under UV light. 100 bp ladder markers (Amersham
induced lymphomagenesis. Genes Dev. 13, 2658–2669.Pharmacia Biotech Inc.) were used to check the size of the PCR products.
The -ARF/p16 products were gel-purified (using QIAGEN QIAquick gel Elenbaas, B., Spirio, L., Koerner, F., Fleming, M.D., Zimonjic, D.B., Donaher,
extraction kit), and 20 ng of product was sequenced using 5 pM of the J.L., Popescu, N.C., Hahn, W.C., and Weinberg, R.A. (2001). Human breast
primers given above and the ABI PRISM BigDye Terminator cycle se- cancer cells generated by oncogenic transformation of primary mammary
quencing. epithelial cells. Genes Dev. 15, 50–65.
Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M.,Cytogenetic analyses
Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosisMetaphases were analyzed by multiplex fluorescence in situ hybridization
in fibroblasts by c-myc protein. Cell 69, 119–128.(M-FISH) using 24 combinatorially labeled probes with five fluorophores to
identify individual chromosomes as recommended by the supplier (Vysis). Felsher, D.W., Zetterberg, A., Zhu, J., Tlsty, T., and Bishop, J.M. (2000).
Image processing was performed using Vysis Quips Spectravysion software. Overexpression of MYC causes p53-dependent G2 arrest of normal fibro-
Genomic DNA was extracted from one 80 cm2 flask each of LTRM and blasts. Proc. Natl. Acad. Sci. USA 97, 10544–10548.
T1–T5 cells using Invitrogen Easy-DNA extraction kit and used for CGH on
Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L., and Conti, C.J.gridded BAC arrays (Pinkel et al., 1998).
(1994). Induction of cyclin D1 overexpression by activated ras. Oncogene
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